Role of Circulating Tumour DNA Testing in Assessing for Alterations of Primary Anti-EGFR Resistance in RAS/RAF Wild-type Metastatic Colorectal Cancer Patients
NCT05051592
·
clinicaltrials.gov ↗
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Sponsor
National University Hospital, Singapore